President of the Group of Biotechnology and Pharmaceutical Industries (BioCubaFarma), Eduardo Martínez, pointed out in a press conference that results in previous studies and the vaccination campaign of children over three years old will allow the evaluation in the target age group.
(to be continued)
pgh/lcr
© 2016-2021 Prensa Latina
Latin American News Agency
Radio – Publications – Videos – News by the minute.
All Rigts Reserved.
St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .
Web Site developed by IT Division Prensa Latina.
